




Searching News Database: Acorda Therapeutics
HSMN NewsFeed - 14 Nov 2018
Grünenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US
Grünenthal Acquires Averitas Pharma and Establishes Commercial Footprint in the US
HSMN NewsFeed - 29 Feb 2016
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
Asterias Biotherapeutics Appoints Stephen L. Cartt President and Chief Executive Officer
HSMN NewsFeed - 30 Jul 2015
Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics
Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics
HSMN NewsFeed - 14 May 2014
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
Acorda Therapeutics Appoints Andrew Hindman as Chief Business Development Officer
HSMN NewsFeed - 15 Sep 2011
Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer
Acorda Therapeutics Announces Enrique Carrazana, M.D. Joins Company as Chief Medical Officer
HSMN NewsFeed - 16 May 2011
Biogen Idec Receives Approval for FAMPYRA in Australia to Improve Walking Ability in Adult Patients with MS
Biogen Idec Receives Approval for FAMPYRA in Australia to Improve Walking Ability in Adult Patients with MS
HSMN NewsFeed - 7 Jul 2010
Acorda Therapeutics Announces Douglas Kargman Joins as Vice President of Drug Safety
Acorda Therapeutics Announces Douglas Kargman Joins as Vice President of Drug Safety
HSMN NewsFeed - 22 Feb 2010
Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs
Acorda Therapeutics Announces Adrian L. Rabinowicz Joins as Senior Vice President of Medical Affairs
HSMN NewsFeed - 3 Feb 2010
Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA (dalfampridine)
Acorda Therapeutics Announces Pricing and Patient Assistance Programs for AMPYRA (dalfampridine)
HSMN NewsFeed - 25 Jan 2010
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
Acorda Therapeutics Announces Lauren Sabella Joins as Executive Vice President of Commercial Development
HSMN NewsFeed - 3 Apr 2008
Acorda Therapeutics Names John Librie Senior Vice President, Sales and Marketing
Acorda Therapeutics Names John Librie Senior Vice President, Sales and Marketing
HSMN NewsFeed - 6 Jun 2007
Acorda Therapeutics Begins Second Phase 3 Clinical Trial of Fampridine-SR in Multiple Sclerosis
Acorda Therapeutics Begins Second Phase 3 Clinical Trial of Fampridine-SR in Multiple Sclerosis
HSMN NewsFeed - 17 Oct 2006
Acorda Therapeutics Announces Expansion of Zanaflex Capsules(TM) Sales Force to 65
Acorda Therapeutics Announces Expansion of Zanaflex Capsules(TM) Sales Force to 65
Additional items found! 12

Members Archive contains
12 additional stories matching:
Acorda Therapeutics
(Password required)
Acorda Therapeutics
(Password required)